Concepedia

Gert de Voer

GD

Statistics

Publications

3

Citations

37

H-Index

3

Active since

2017

Affiliations

Merck B.V. (Netherlands)(Current)

Merck KGaA, Darmstadt (Germany)

Gert de Voer is an author at Merck B.V. (Netherlands) specializing in multiple sclerosis, neurology, and pharmacotherapy.

Publications per year

2017–2022

3

Publications

3

Patient adherence to subcutaneous IFN beta-1a injections using the RebiSmart<sup>®</sup> injection device: a retrospective real-world study among Dutch and German patients with multiple sclerosis

Marieke Krol, Gert de Voer, Ulrike Osowski · Patient Preference and Adherence · 2017 · 13 citations · Full text

, , +8

Healthcare utilization and costs of multiple sclerosis patients in the Netherlands: a healthcare claims database study

Servaas Buijs, Marieke Krol, Gert de Voer · Journal of Comparative Effectiveness Research · 2018 · 12 citations · Full text

, , +12

The longitudinal relationship between fatigue, depression, anxiety, disability, and adherence with cognitive status in patients with early multiple sclerosis treated with interferon beta-1a

Hanne van Ballegooijen, Karin van der Hiele, Christian Enzinger et al. · eNeurologicalSci · 2022 · 12 citations · Full text

, , +17

1–3 of 3